Fungal Infections in Immunocompromised Hosts
A special issue of Journal of Fungi (ISSN 2309-608X).
Deadline for manuscript submissions: closed (31 October 2018) | Viewed by 103233
Special Issue Editors
Interests: fungal pathogenesis; clinical mycology; resistance; fungal diagnostics; experimental antifungals; mold infections; infections in cancer patients; infectious diseases; medical mycology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
First convened in 1980, the International Immunocompromised Host Society (ICHS) symposium is the premier, international, multi-disciplinary forum for scientific and clinical exchange to improve understanding and management of infections in the immunocompromised host. Since its inception, mycology has been a key theme throughout the bi-annual meetings. The recent meeting in June 2018, in Athens, Greece, similarly, had a cutting edge mycology program delivered by leading international experts addressing current and future innovations in mycology.
Worldwide deaths from Candida, Aspergillus, Pneumocystis and Cryptococcus infections are estimated to exceed 1.4 million annually with individual patient mortality rates in excess of 30%. Invasive fungal diseases (IFDs) are occurring in expanding populations at risk, such as those with liver disease and receiving novel treatments, such as biologics and small molecule protein kinase inhibitors, providing insight into fungal pathogenesis. Outbreaks occurring in healthcare or after natural disasters are increasingly identified requiring specialized investigation. The emerging global problem of antifungal resistance has prompted an increasing focus on antifungal drug discovery, as well as optimizing PK/PD of antifungals, and on fungal biofilms, which may select resistance. Approaches such as harnessing the mycobiome and immunotherapy may offer new options for managing IFD.
The development and integration of improved diagnostic tests for IFD including MALDI-TOF, nucleic acid and biomarker detection and immunogenetic assays offers promise for implementing more precise individual risk profiles and early intervention to prevent or treat IFD. At a population level these tests offer important antifungal stewardship tools to support the judicious use of antifungals. In this unique supplement we have compiled several state of the art topics that are based on lectures delivered by eminent mycology experts during the 37th ICHS meeting. We hope that the esteemed audience of Journal of Fungi will enjoy and appreciate the ever evolving and complex field of fungal infections in vulnerable hosts.
Sincerely,
Prof. Dimitrios P. Kontoyiannis
Prof. Monica Slavin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Candida
- Aspergillus
- Cryptococcucus
- endemic fungii
- resistance
- fungal diagnostics
- fungal epidemiology
- fungal pharmacology
- antifungal agents
- immunocompromised host
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Fungal Infections in Immunocompromised Hosts 2.0 in Journal of Fungi (7 articles)